Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study
PaperCitations, authors & open-access status
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 422 citations, 2017 year and hybrid oa status.
422
Citations
2017
Year
hybrid
OA Status